Testing effectiveness (Phase 2)Study completedNCT01094548
What this trial is testing
Study of Tecemotide (L-BLP25) in Subjects With Slowly Progressive Multiple Myeloma With no Symptoms and Who Have Had no Chemotherapy
Who this might be right for
Multiple Myeloma
Merck KGaA, Darmstadt, Germany 34